Facebook
X
LinkedIn
ForwardHemeHub Hematology Summit 2026 (JS2610A)
The HemeHub Hematology Summit 2026 is a one‑day, hybrid CME activity designed to deliver comprehensive, evidence‑based updates in classical and malignant hematology. The program features expert‑led presentations and case‑based discussions addressing evolving standards of care, emerging therapeutic options, and practical management challenges across hematologic malignancies and nonmalignant hematologic disorders. Given the rapidly expanding therapeutic landscape—including cellular therapies, targeted agents, and updated clinical guidelines—there remains a demonstrated need for hematology professionals to strengthen competency in current best practices and implementation strategies.
Target Audience
This activity convenes academic faculty, community physicians, advanced practice providers, trainees, nurses, advocacy representatives, and other members of the oncology care team to address identified practice gaps, enhance clinical decision‑making, and support the delivery of evidence‑based, high‑quality care for patients in Texas and nationwide.
Learning Objectives
- Interpret emerging clinical trial data and updated national guideline recommendations relevant to contemporary hematology practice.
- Evaluate the evolving role of targeted and cellular therapies, including chimeric antigen receptor T cell–based approaches, and determine appropriate patient selection and timing of referral for advanced interventions.
- Apply evidence-based treatment sequencing and risk stratification principles in complex patient scenarios using a case based clinical framework.
- Recognize and discuss clinically significant toxicities associated with advanced therapeutic modalities to optimize patient safety and treatment continuity.
- Implement practical strategies for multidisciplinary coordination and collaboration between community and academic practice settings to facilitate timely, guideline aligned care.
- Integrate updated evidence and expert clinical insights into routine practice workflows to reduce variation and enhance consistency of hematologic care delivery.
Course summary
- 5.00 AMA
- 5.00 Attendance
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of The University of Texas Southwestern Medical Center and HemeHub. The University of Texas Southwestern Medical Center is accredited by the ACCME to provide continuing medical education for physicians.
Physician
The University of Texas Southwestern Medical Center designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Non-Physician
The University of Texas Southwestern Medical Center certifies that non-physicians will receive an attendance certificate stating that they participated in the activity that was designated for 5.0 AMA PRA Category 1 Credits™.
Available Credit
- 5.00 AMA
- 5.00 Attendance
Price
Certificate
select the "Take Course" button to complete the course evaluation and to retrieve your certificate.
If you do not see the "Take Course" button, login to your EthosCE account or create an account using the email address used during the course registration or activity sign-in*. A profile can be created at the following link:
https://cme.utsouthwestern.edu/user/register
In order to access the course to retrieve a CME certificate the email provided at activity sign-in* must match the email in your EthosCE profile. If you provided an email different from your EthosCE profile please contact the CME office at [email protected]. If you have not already created a profile in EthosCE, please create one using the same email provided during the course registration or activity sign-in*.
*Course administrators may have retrieved the email address from the course registration, the organization directory or during the course/activity sign-in.